STTK Reports $0 Revenue, $0 EPS, Phase 1 SL-325 Data Q2 2026, Phase 2 Crohn's Q3 2026, $21.4M ATM Proceeds
Shattuck Labs, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $5.65
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS